mFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRC
Clinical trial NCT04895137 · COMPLETED
Trial details
- NCT number
- NCT04895137
- Sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-01
- Primary completion
- 2024-09-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.